Literature DB >> 9281905

On the validity of the dispersion model of hepatic drug elimination when intravascular transit time densities are long-tailed.

M Weiss1, C Stedtler, M S Roberts.   

Abstract

The dispersion model with mixed boundary conditions uses a single parameter, the dispersion number, to describe the hepatic elimination of xenobiotics and endogenous substances. An implicit a priori assumption of the model is that the transit time density of intravascular indicators is approximately by an inverse Gaussian distribution. This approximation is limited in that the model poorly describes the tail part of the hepatic outflow curves of vascular indicators. A sum of two inverse Gaussian functions is proposed as an alternative, more flexible empirical model for transit time densities of vascular references. This model suggests that a more accurate description of the tail portion of vascular reference curves yields an elimination rate constant (or intrinsic clearance) which is 40% less than predicted by the dispersion model with mixed boundary conditions. The results emphasize the need to accurately describe outflow curves in using them as a basis for determining pharmacokinetic parameters using hepatic elimination models.

Mesh:

Substances:

Year:  1997        PMID: 9281905     DOI: 10.1007/bf02459999

Source DB:  PubMed          Journal:  Bull Math Biol        ISSN: 0092-8240            Impact factor:   1.758


  14 in total

1.  An isolated in-situ rat head perfusion model for pharmacokinetic studies.

Authors:  K A Foster; G D Mellick; M Weiss; M S Roberts
Journal:  Pharm Res       Date:  2000-02       Impact factor: 4.200

2.  Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

3.  Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.

Authors:  M S Roberts; Y G Anissimov
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

4.  A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.

Authors:  Yuri G Anissimov; Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-04       Impact factor: 2.745

5.  Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Authors:  Peng Li; Thomas A Robertson; Qian Zhang; Linda M Fletcher; Darrell H G Crawford; Michael Weiss; Michael S Roberts
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

Review 6.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

7.  Exponential tails of drug disposition curves: reality or appearance?

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12-13       Impact factor: 2.745

8.  On the degree of solute mixing in liver models of drug elimination.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1997-06

9.  Metabolite mean transit times in the liver as predicted by various models of hepatic elimination.

Authors:  G D Mellick; Y G Anissimov; A J Bracken; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

10.  Fractal structure of the liver: effect on drug elimination.

Authors:  Michael Weiss
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-05       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.